IDS Launch Two Rapid Antigen Tests for COVID-19

We are pleased to announce that we are now able provide a range of rapid, point of care SARS-CoV-2 antigen tests. These tests detect patients who are currently infected with SARS-CoV-2, more commonly known as the COVID-19 virus: Rapid Antigen Test 1: Lateral flow cassette with nasopharyngeal swab included Rapid Antigen Test 2: Lateral flow […]

Launch of the IDS Cortisol assay on the IDS-iSYS Multi-Discipline Automated System

The IDS Cortisol assay is a fully automated CLIA assay for the quantitative determination of cortisol in human serum and plasma samples. Measurement of Cortisol concentrations can be used to assist in the diagnosis and treatment of disorders of the adrenal gland, such as hypo- and hyper-cortisolism, most commonly referred to as Addison’s disease and […]

Expanding the IDS Allergy Panel

We are excited to announce that we have added 7 new clinically relevant allergens to our portfolio, expanding to 67 allergens since our launch last year. The first screening mix is now available to help in the diagnosis of grass allergies. The tree nuts Hazelnut, Almond and Pistachio, which belong to the ‘Big 8’ of […]